psychology

#401      35 min 16 sec
Why feeling pain is key to our happiness

Associate Professor Brock Bastian

Research psychologist Brock Bastian argues that a willingness to experience pain is crucial to our pursuit of genuine happiness, and that our efforts to escape unpleasantness or seek out only the positive in fact weaken us in managing life's inevitable difficulties. Presented by Eric van Bemmel.

#390      25 min 51 sec
The human cost of hate: The lasting damage caused by homophobia and transphobia

Prof Michael King

Psychiatric epidemiologist Professor Michael King discusses the devastating psychological harm suffered by victims of homophobia and transphobia. He also examines the role of families, governments and religion in curbing the problem. Presented by Lynne Haultain.

 

#387      30 min 53 sec
Team positive: Taking the science of wellbeing to a systems level

Associate Professor Lindsay Oades

Research psychologist Associate Professor Lindsay Oades explains how positive psychology and wellbeing literacy, once largely focused on the individual, are being taken to a group level to promote healthier, more skillful interactions in organisations and human networks. Presented by Dr Andi Horvath.

#378      33 min 48 sec
Show me the data: Sifting pseudoscience from the real thing

Prof Scott Lilienfeld

In a world with a bewildering mix of fact and fiction, and in which social and mainstream media only add to the confusion, how do we separate out false or dubious claims from the well-founded and evidence-based? Research and clinical psychologist Prof Scott Lilienfeld joins science host Dr Andi Horvath to help us distinguish pseudoscience from the real thing by exploring popular myths that too often make fools of us.

#373      30 min 45 sec
Ongoing symptoms: Why isn't treatment for depression and anxiety leading to lower prevalence?

Prof Tony Jorm

Public health researcher Prof Tony Jorm asks why prevalence of anxiety and depression in North America, Australia and elsewhere has not decreased despite a quarter century of more and better treatment for two of the world's most common mental health problems. Presented by Eric van Bemmel.

#369      39 min 00 sec
The necessity of kindness: Altruism in animals and beyond

Prof Lee Dugatkin

Evolutionary biologist and historian of science Prof Lee Dugatkin joins Dr Andi Horvath to discuss displays of altruism in insects, animals and humans, and how the often harsh evolutionary imperatives of survival can actually accommodate, promote or depend on acts of kindness and justice.

#368      31 min 43 sec
Decision neuroscience: Emerging insights into the way we choose

Prof Peter Bossaerts

Decision science researcher Prof Peter Bossaerts argues that investigating brain activity as we make decisions is generating new insights into how we deal with uncertainty and risk. Once the domain of economists and psychologists, the study of human decision-making is increasingly taking a neuron-level view, with implications well beyond economics and finance. Presented by Eric van Bemmel.

#367      19 min 05 sec
Publish AND perish: Science and medical researchers under pressure

Dr Joeri Tijdink

Psychiatrist Joeri Tijdink discusses his research into how increasing pressures on science and medical researchers to win funding, achieve positive research results, and publish in highly esteemed journals may be linked to professional burnout and even research misconduct. Presented by Dr Andi Horvath.

#344      35 min 17 sec
Brain ever changing: Neuroplasticity and its role in mental health

Prof Anthony Hannan

Behavioural neuroscientist Prof Anthony Hannan gives a neuro-researcher’s view of the dynamic, bidirectional interplay of brain and body, and the protective and destructive implications for both our mental and physical health. Presented by Dr Andi Horvath.

#343      29 min 55 sec
Cannabis research: The state of the science in an age of weed liberalization

Prof David Castle

Psychiatrist and clinical researcher Prof David Castle discusses how cannabis represents both a public health risk and a wide-ranging therapeutic opportunity, as the once “evil weed” gains greater legal acceptance for recreational and medical use. Presented by Eric van Bemmel.